One thing the big-cap pharma companies have done is to return money to shareholders, Cramer said. "They're all about bringing out values. Pfizer Pfizer has done a series of gigantic moves to bring out value."
He said the takeaway for a Merck or a Johnson & Johnson is all very clear, he said. These companies make a lot of money and they have good balance sheets and they continue to return capital. "So, they've become banks for foreigners."
He added, These groups are a better safe haven than any other group in the market."
"Pharma isn't what it was a decade ago," Urken agreed. "Keep it on your radar. In this kind of a market it's a group that continues to work."
To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here.